Get the Stockscreener App
37.05
4.48%
-1.77
Twist Bioscience Corp stock is traded at $37.05, with a volume of 539.84K.
It is down -4.48% in the last 24 hours and down -29.71% over the past month.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
See More
Previous Close:
$38.82
Open:
$39.04
24h Volume:
539.84K
Relative Volume:
0.66
Market Cap:
$2.23B
Revenue:
$277.49M
Net Income/Loss:
$-192.14M
P/E Ratio:
-11.03
EPS:
-3.36
Net Cash Flow:
$-95.52M
1W Performance:
-10.00%
1M Performance:
-29.71%
6M Performance:
-9.48%
1Y Performance:
-4.66%
1-Day Range:
$36.34
$39.27
1-Week Range:
$36.34
$42.64
52-Week Range:
$27.41
$60.90
Twist Bioscience Corp Stock (TWST) Company Profile
Name
Twist Bioscience Corp
Sector
Industry
Phone
800-719-0671
Address
681 GATEWAY BLVD., SOUTH SAN FRANCISCO, CA
Compare TWST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TWST
Twist Bioscience Corp
|
37.07 | 2.23B | 277.49M | -192.14M | -95.52M | -3.36 |
|
TMO
Thermo Fisher Scientific Inc
|
525.32 | 198.19B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
207.37 | 148.92B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
128.05 | 36.52B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IDXX
Idexx Laboratories Inc
|
440.00 | 35.63B | 3.90B | 887.87M | 798.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
188.22 | 33.12B | 15.41B | 1.37B | 2.11B | 7.50 |
Twist Bioscience Corp Stock (TWST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Jun-04-24 | Initiated | Guggenheim | Buy |
| Jan-17-24 | Upgrade | Goldman | Neutral → Buy |
| Sep-27-23 | Initiated | Berenberg | Buy |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-03-23 | Upgrade | Evercore ISI | In-line → Outperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-29-21 | Initiated | William Blair | Outperform |
| Jun-04-21 | Initiated | Goldman | Neutral |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Feb-05-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-20-20 | Initiated | SVB Leerink | Mkt Perform |
| May-31-19 | Initiated | Evercore ISI | Outperform |
| Nov-26-18 | Initiated | JP Morgan | Neutral |
View All
Twist Bioscience Corp Stock (TWST) Latest News
Why Investors Shouldn't Be Surprised By Twist Bioscience Corporation's (NASDAQ:TWST) 26% Share Price Plunge - Simply Wall St
Twist Bioscience Co. (NASDAQ:TWST) Receives $54.40 Average Price Target from Brokerages - Defense World
Is Twist Bioscience Corporation (TWST) The Best Immunology Stock To Buy Now? - Insider Monkey
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday - Benzinga
Handelsbanken Fonder AB Purchases New Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Rhumbline Advisers Raises Stake in Twist Bioscience Co. (NASDAQ:TWST) - Defense World
ARK Investment Management LLC Purchases 237,772 Shares of Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience Corp. to Host Earnings Call - ACCESS Newswire
Brokerages Set Twist Bioscience Co. (NASDAQ:TWST) Target Price at $54.40 - MarketBeat
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Principal Financial Group Inc. - Defense World
New York State Common Retirement Fund Has $20.54 Million Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience to Present at Upcoming Investor Conferences - Business Wire
Van ECK Associates Corp Acquires 267 Shares of Twist Bioscience Co. (NASDAQ:TWST) - Defense World
Is Now The Time To Buy Twist Bioscience Corp (NASDAQ: TWST) Stock? - Stocks Register
Baillie Gifford & Co. Cuts Stock Position in Twist Bioscience Co. (NASDAQ:TWST) - MarketBeat
Twist Bioscience Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Yahoo Finance
Cathie Wood’s ARK ETF adds Twist Bioscience, Beam Therapeutics stock By Investing.com - Investing.com Australia
Cathie Wood's ARK ETF adds Twist Bioscience, Beam Therapeutics stock - Investing.com
Cathie Wood’s ARK ETF adds Twist Bioscience, Beam Therapeutics stock - Investing.com India
Cathie Wood's ARK ETF adds Twist Bioscience, Beam Therapeutics stock By Investing.com - Investing.com UK
Bioscience industry in Oregon outpaces overall job growth - The Business Journals
Twist Bioscience Co. (NASDAQ:TWST) Director Robert Chess Sells 2,940 Shares - MarketBeat
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday - Benzinga
Twist Bioscience director Robert Chess sells shares totaling $156,216 - MSN
IBD Rating Upgrades: Twist Bioscience Shows Improved Relative Price Strength - MSN
Twist Bioscience (NASDAQ:TWST) Stock Price Down 5.8%Here's What Happened - MarketBeat
Cathie Wood's ARK sells Palantir and Roku, buys more Twist Bioscience - MSN
Twist Bioscience Reports Record Quarterly Revenue - TipRanks
Twist Bioscience Co. (NASDAQ:TWST) Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Twist Bioscience approves stock increase, officer exculpation - MSN
Twist Bioscience approves stock increase, officer exculpation By Investing.com - Investing.com Australia
Director’s Strategic Sale of Twist Bioscience Shares - TipRanks
Twist Bioscience director Robert Chess sells shares totaling $156,216 By Investing.com - Investing.com Nigeria
Twist Bioscience Stockholders Approve Key Amendments - TipRanks
Twist Bioscience SVP sells $62,134 in common stock - MSN
Cathie Wood’s ARK sells Palantir and Roku, buys more Twist Bioscience - Investing.com Nigeria
Cathie Wood's ARK sells Palantir and Roku, buys more Twist Bioscience By Investing.com - Investing.com South Africa
Dennis Cho Sells 806 Shares of Twist Bioscience Co. (NASDAQ:TWST) Stock - MarketBeat
Insider Selling: Twist Bioscience Co. (NASDAQ:TWST) SVP Sells 1,259 Shares of Stock - MarketBeat
Twist Bioscience (NASDAQ:TWST) Trading Down 3.7%Should You Sell? - MarketBeat
William Blair Lifts Earnings Estimates for Twist Bioscience - MarketBeat
Twist Bioscience Corp Stock (TWST) Financials Data
Revenue
Net Income
Cash Flow
EPS
Twist Bioscience Corp Stock (TWST) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WERNER ROBERT F. | Chief Accounting Officer |
Feb 21 '25 |
Sale |
44.18 |
267 |
11,795 |
52,591 |
| Cho Dennis | See Remarks |
Feb 21 '25 |
Sale |
44.18 |
526 |
23,237 |
112,261 |
| Finn Patrick John | President and COO |
Feb 21 '25 |
Sale |
44.18 |
1,839 |
81,242 |
267,724 |
| Green Paula | SVP of Human Resources |
Feb 21 '25 |
Sale |
44.18 |
618 |
27,301 |
131,830 |
| Laponis Adam | Chief Financial Officer |
Feb 21 '25 |
Sale |
44.18 |
918 |
40,554 |
109,496 |
| Leproust Emily M. | Chief Executive Officer |
Feb 21 '25 |
Sale |
44.18 |
2,790 |
123,254 |
665,094 |
3.79%
2.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):